Key statistics
As of last trade, Immunovia AB (publ) (IMMNOV:STO) traded at 0.935, 266.18% above the 52 week low of 0.2553 set on Oct 25, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.96 |
---|---|
High | 0.96 |
Low | 0.911 |
Bid | 0.915 |
Offer | 0.935 |
Previous close | 0.949 |
Average volume | 2.29m |
---|---|
Shares outstanding | 181.15m |
Free float | 172.52m |
P/E (TTM) | -- |
Market cap | 171.91m SEK |
EPS (TTM) | -1.30 SEK |
Data delayed at least 15 minutes, as of Sep 20 2024 08:14 BST.
More ▼
- Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference
- Immunovia Publishes Interim Report for January-June 2024
- Immunovia's next-generation test to be included in large study of pancreatic cysts funded by the U.S. National Institutes of Health
- Immunovia files US patent application to protect its next-generation test
- Immunovia completes development of its pancreatic cancer detection test after substantially increasing test accuracy
- Invitation to Immunovia's Q2 presentation
- Immunovia presents data from discovery study at 2024 PancreasFest medical conference
- Immunovia's new lab staffed and operational after rapid implementation
More ▼